Join to View Full Profile
12040 NE 128th StStop 11Kirkland, WA 98034
Phone+1 425-899-3123
Fax+1 425-899-3114
Dr. Burdick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 2007 - 2010- Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2006 - 2007
Johns Hopkins University School of MedicineClass of 2006
Certifications & Licensure
WA State Medical License 2010 - 2026
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Modular EHR, Cerner Corporation, 2013
Clinical Trials
- A Pilot Study of Mirabegron and Behavioral Modification Including Pelvic Floor Exercise for Overactive Bladder in Parkinson's Disease (MAESTRO) Start of enrollment: 2014 Mar 01
- Flexible-Dose Trial in Early Parkinson's Disease (PD) Start of enrollment: 2020 Jan 06
- Open-label Trial in Parkinson's Disease (PD) Start of enrollment: 2021 Feb 24
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsA Randomized Phase 3 Study Comparing P2B001 to its Components (Low-Dose Extended-Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended-Releas...C Warren Olanow, Robert A Hauser, Daniel J Burdick, Rohit Dhall, Joy Antonelle de Marcaida
Movement Disorders. 2024-02-01 - 26 citationsSafety, tolerability, and efficacy of NLY01 in early untreated Parkinson's disease: a randomised, double-blind, placebo-controlled trial.Andrew McGarry, Shane Rosanbalm, Mika Leinonen, C Warren Olanow, Dennis To
The Lancet. Neurology. 2024-01-01 - 5 citationsImproving levodopa delivery: IPX203, a novel extended-release carbidopa-levodopa formulation.Peter LeWitt, Aaron Ellenbogen, Daniel Burdick, Steven Gunzler, Ramon Gil
Clinical Parkinsonism & Related Disorders. 2023-01-01
Press Mentions
1st Patient Treated in SHAPE Trial of ATH-1017 for Parkinson’s DementiaJanuary 28th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
